Cheryl Gault
Chief Operating Officer, Korsana Biosciences, Inc.
Companies
- Rapport Therapeutics, Inc.Chief operating officer Feb 4, 2025 to now1
- Rapport Therapeutics, Inc.Chief Operations Officer Jun 6, 2024 to Jun 10, 20242
- Korsana Biosciences, Inc.Chief operating officer Jan 11, 2021 to Jan 24, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Rapport Therapeutics, Inc. RAPP149,914 shares4$4.3M at $28.65Jun 30, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Sold 1,000 shares at $43.15 of Rapport Therapeutics, Inc.4
- Jun 30, 2026Sold 3,308 shares at $42.17 of Rapport Therapeutics, Inc.4
- Jun 30, 2026Sold 3,792 shares at $41.39 of Rapport Therapeutics, Inc.4
- Jun 30, 2026Sold 1,900 shares at $40.09 of Rapport Therapeutics, Inc.4
- Mar 30, 2026Sold 2,839 shares at $28.55 of Rapport Therapeutics, Inc.5
- Mar 30, 2026Sold 7,161 shares at $28.04 of Rapport Therapeutics, Inc.5
- Mar 5, 2026Sold 2,014 shares at $28.93 of Rapport Therapeutics, Inc.6
- Nov 26, 2025Sold 5,000 shares at $30.10 of Rapport Therapeutics, Inc.7
- Nov 26, 2025Exercised options 5,000 shares at $1.80 of Rapport Therapeutics, Inc.7
- Sep 8, 2025Sold 5,000 shares at $38.33 of Rapport Therapeutics, Inc.8
- Sep 8, 2025Exercised options 5,000 shares at $1.80 of Rapport Therapeutics, Inc.8
- Mar 3, 2025Granted 13,987 shares of Rapport Therapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 31, 2026
- 6SEC EDGARForm 4 filed Mar 9, 2026
- 7SEC EDGARForm 4 filed Dec 1, 2025
- 8SEC EDGARForm 4 filed Sep 10, 2025
- 9SEC EDGARForm 4 filed Mar 5, 2025